Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues
Reexamination Certificate
2008-05-27
2008-05-27
Ulm, John (Department: 1649)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
C435S069100, C435S069700, C536S023400, C536S023500
Reexamination Certificate
active
10504973
ABSTRACT:
Various embodiments of the invention provide human receptors and membrane-associated proteins (REMAP) and Q polynucleotides which identify and encode REMAP. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of REMAP.
REFERENCES:
patent: 5175383 (1992-12-01), Leder et al.
patent: 5270163 (1993-12-01), Gold et al.
patent: 5474796 (1995-12-01), Brennan
patent: 5605662 (1997-02-01), Heller et al.
patent: 5686242 (1997-11-01), Bruice et al.
patent: 5707618 (1998-01-01), Armentano et al.
patent: 5767337 (1998-06-01), Roses et al.
patent: 5804413 (1998-09-01), DeLuca
patent: 5807522 (1998-09-01), Brown et al.
patent: 5837458 (1998-11-01), Minshull et al.
patent: 5840484 (1998-11-01), Seilhamer et al.
patent: 5910434 (1999-06-01), Rigg et al.
patent: 5914236 (1999-06-01), Monsma, Jr. et al.
patent: 5932435 (1999-08-01), Atkins et al.
patent: 5997848 (1999-12-01), Patton et al.
patent: 6022691 (2000-02-01), Bruice et al.
patent: 6057101 (2000-05-01), Nandabalan et al.
patent: 6372724 (2002-04-01), Pelleg et al.
patent: 7063846 (2006-06-01), Rikihisa et al.
patent: WO84/03564 (1984-09-01), None
patent: WO95/25116 (1995-09-01), None
patent: WO95/35505 (1995-12-01), None
Ackerman, S.L. et al., “The mouse rostral cerebellar malformation gene encodes an UNC-5-like protein,” (1997) Nature 386:838-842.
Adam, M.A. et al., “Identification of a signal in a murine retrovirus that is sufficient for packaging of nonretroviral RNA into virions,” (1988) J. Virol. 62:3802-3806.
Aisenberg, A.C. et al., “Rearrangement of the gene for the beta chain of the T-cell receptor in T-cell chronic lymphocytic leukemia and related disorders,” (1985) N. Engl. J. Med. 313:529-533.
Altschul, S.F. et al., “Basic local alignment search tool,” (1990) J. Mol. Biol. 215:403-410.
Anderson, N.L. et al., “A comparison of selected mRNA and protein abundances in human liver,” (1997) Electrophoresis 18:533-537.
Antinozzi, P.A. et al., “Metabolic engineering with recombinant adenoviruses,” (1999) Annu. Rev. Nutr. 19:511-544.
Arap, W. et al., “Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model,” (1998) Science, 279:377-380.
Armentano, D. et al., “Effect of internal viral sequences on the utility of retroviral vectors,” (1987) J. Virol. 61:1647-1650.
Arndt, G.M. et al., “A rapid genetic screening system for identifying gene-specific suppression constructs for use in human cells,” (2000) Nucleic Acids Res. 28:E15.
Ashkenazi, A. et al., “Apoptosis control by death and decoy receptors,” (1999) Curr. Opin. Cell Biol. 11:255-260.
Baldwin, A.M., “Structure and function of receptors coupled to G proteins,” (1994) Curr. Opin. Cell Biol. 6:180-190.
Baltimore, D., “Intracellular Immunization,” (1988) Nature 335:395-396.
Bauer, G. et al., “Inhibition of human immunodeficiency virus-1 (HIV-1) replication after transduction of granulocyte colony-stimulating factor-mobilized D34+cells from HIV-1-Infected donors using retroviral vectors containing anti-HIV genes,” (1997) Blood 89:2259-2267.
Bender, M.A. et al., “Evidence that the packaging signal of Moloney murine leukemia virus extends into the gag region,” (1987) J. Virol. 61:1639-1646.
Bitter, G.A. et al., “Expression and secretion vectors for yeast,” (1987) Methods Enzymol. 153:516-544.
Blaese, R.M. et al., “T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 7 years,” (1995) Science 270:475-480.
Blind, M. et al., “Cytoplasmic RNA modulators of an inside-out signal-transduction cascade,” (1999) Proc. Nat. Acad. Sci. USA 96:3606-3610.
Boado, R.J. et al., “Drug delivery of antisense molecules to the brain for treatment of Alzheimer's disease and cerebral AIDS,” (1998) J. Pharm. Sci. 87:1308-1315.
Bolton, A.E. et al., “The labelling of proteins to high specific radioactivities by conjugation to a 1251-containing acylating agent,” (1973) Biochem. J. 133:529-539.
Bonyhadi, M.L., “RevM10-expressing T cells derived in vivo from transduced human hematopoietic stem-progenitor cells inhibit human immunodeficiency virus replication,” (1997) J. Virol. 71:4707-4716.
Bordignon, C. et al., “Gene therapy in peripheral blood lymphocytes and bone marrow for ADA-immunodeficient patients,” (1995) Science 270:470-475.
Boulay, J.-L. et al., “Expression vectors and delivery systems,” (1998) Curr. Opin. Biotechnol. 9:445-450.
Brody, E.N. et al., “Aptamers as therapeutic and diagnosis agents,” (2000) J. Biotechnol. 74:5-13.
Broglie, R. et al., “Light-regulated expression of a pea Ribulose-1,5-Bisphosphate Carboxylase small subunit gene in transformed plant cells,” (1984) Science 334:838-843.
Brose, K. et al., “Slit proteins bind robo receptors and have an evolutionarily conserved role in repulsive axon guidance,” (1999) Cell 96:795-806.
Brummelkamp, T.R. et al., “A system for stable expression of short interfering RNAs in mammalian cells,” (2002) Science 296:550-553.
Buller, R.M. et al., “Decreased virulence of recombinant Vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype,” (1985) Nature 317:813-815.
Burge, C. et al., “Finding the genes in genomic DNA,” (1997) J. Mol. Biol. 268:78-94.
Burge, C. et al., “Prediction of complete gene structures in human genomic DNA,” (1998) Curr. Opin. Struct. Biol. 8:346-354.
Burton, D.R., “A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals,” (1991) Proc. Natl. Acad. Sci. USA 88:10134-10137.
Capecchi, M.R., “Altering the genome by homologous recombination,” (1989) Science 244:1288-1291.
Caruthers, M.H. et al., “New chemical methods for synthesi in polynucleotides,” (1980) Nucleic Acids Symp. Ser. 7:215-223.
Cavazzano-Calvo, M. et al., “Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease,” (2000) Science 288:669-672.
Chang, C.-C. et al., “Evolution of a cytokine using DNA family shuffling,” (1999) Nat. Biotechnol. 17:793-797.
Charng, M.J. et al., “A novel protein distinguishes between quiescent and activated forms of the type I transforming growth factor β Receptor,” (1998) J. Biol. Chem. 273:9365-9368.
Chen, L. et al., “Overexpression of matrix Gla protein mRNA in malignant human breast cells: isolation by differential cDNA hybridization,” (1990) Oncogene 5:1391-1395.
Chicz, R.M. et al., “High-performance liquid chromatography: effective protein purification by various chromatographic modes,” (1990) Methods Enzymol. 182:392-421.
Christians, F.C. et al., “Directed evolution of thymidine kinase for AZT phosphorylation using DNA family shuffling,” (1999) Nat. Biotechnol. 17:259-264.
Clarke, M.L. et al., “Comparative analysis of artificial antisense RNA regulation in fussion yeast and human cells,” (2000) Biochem. Biophys. Res. Commun. 268:8-13.
Colbere-Garapin, F. et al., “A new dominant hybrid selective marker for higher eukaryotic cells,” (1981) J. Mol. Biol. 150:1-14.
Cole, S.P. et al., “Human monoclonal antibodies,” (1984) Mol. Cell Biol. 62:109-120.
Coruzzi, G. et al., “Tissue-specific and light-regulated expression of a pea nuclear gene encoding the small subunit of rebulose-1,5-bisphoshpate carboxylase,” (1984) EMBO J. 3:1671-1680.
Cote, R.J. et al., “Generation of human monoclonal antibodies reactive with cellular antigene,” (1983) Proc. Natl. Acad. Sci. USA 80:2026-2030.
Crameri, A. e
Baughn Mariah R.
Becha Shanya D.
Bulloch Sean A.
Chawla Narinder K.
Chien David
Foley & Lardner LLP
Incyte Corporation
Ulm John
LandOfFree
CD40-related receptor that binds CD40L does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with CD40-related receptor that binds CD40L, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and CD40-related receptor that binds CD40L will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3923621